Gyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	37.07	11.81	33.51	25.18
Short-Term Investments	15.36	14.86	-	-
Cash & Short-Term Investments	52.43	26.67	33.51	25.18
Cash Growth	96.56%	-20.41%	33.10%	-
Accounts Receivable	31.08	19.59	15.16	15.61
Other Receivables	0.23	5.19	1.29	-
Receivables	36.95	29.15	16.84	17.14
Inventory	10.17	6.34	4.28	6.12
Prepaid Expenses	1.34	1.19	1.55	0.38
Other Current Assets	1.49	1.44	1.05	0.84
Total Current Assets	102.37	64.79	57.22	49.65
Property, Plant & Equipment	24.73	25.7	23.78	18.38
Long-Term Investments	25.12	26.17	23.43	7.39
Other Intangible Assets	6.15	1.71	1.7	1.86
Long-Term Deferred Tax Assets	6.87	5.62	4.7	4.08
Other Long-Term Assets	0.89	1.43	5.72	3.39
Total Assets	166.13	125.41	116.54	84.75
Accounts Payable	0.12	0.11	0.36	0.12
Accrued Expenses	12.09	9.3	10.56	6.77
Current Portion of Leases	0.64	0.71	0.21	0.49
Current Income Taxes Payable	2.94	2.83	5.05	2.1
Current Unearned Revenue	0.11	0.16	0.08	0.17
Other Current Liabilities	2.39	6.41	3.79	2.59
Total Current Liabilities	18.29	19.52	20.05	12.24
Long-Term Leases	0.3	0.89	0.2	0.12
Long-Term Unearned Revenue	0.85	0.93	0.21	0.12
Other Long-Term Liabilities	4.41	5.68	17.61	0.06
Total Liabilities	23.85	27	38.07	12.54
Common Stock	0.09	0.09	0.08	0.06
Additional Paid-In Capital	172.05	136.19	68.18	32.8
Retained Earnings	-65.33	-70.36	-82.44	10.06
Comprehensive Income & Other	-0.78	-2.6	-1.64	-0.39
Total Common Equity	106.03	63.32	-15.83	42.52
Minority Interest	36.25	35.08	29.78	29.7
Shareholders' Equity	142.28	98.4	78.47	72.22
Total Liabilities & Equity	166.13	125.41	116.54	84.75
Total Debt	0.94	1.6	0.41	0.61
Net Cash (Debt)	51.49	25.07	33.1	24.56
Net Cash Growth	105.34%	-24.25%	34.76%	-
Net Cash Per Share	0.50	0.25	0.50	0.32
Filing Date Shares Outstanding	91.31	93.61	85.42	63.59
Total Common Shares Outstanding	91.31	86.31	76.6	63.59
Working Capital	84.08	45.27	37.17	37.41
Book Value Per Share	1.16	0.73	-0.21	0.67
Tangible Book Value	99.88	61.61	-17.53	40.67
Tangible Book Value Per Share	1.09	0.71	-0.23	0.64
Buildings	19.57	18.98	12.29	10.84
Machinery	10.84	10.28	7.39	5.69
Construction In Progress	0.77	0.22	7.88	4.85
Leasehold Improvements	-	-	-	0.33

Source: S&P Capital IQ. Standard template. Financial Sources.